{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-21-023935","form_type":"8-K","ticker":"CRBP","cik":"0001595097","company_name":"Corbus Pharmaceuticals Holdings, Inc.","filed_at":"2021-09-28T23:59:59+00:00","discovered_at":"2026-05-14T18:04:18.729313+00:00","generated_at":"2026-06-29T01:00:26.560519+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Corbus appoints Craig Millian as Chief Operating Officer, effective Sept 27","bullets":["Craig Millian appointed COO effective Sept 27, 2021; previously served as Chief Commercial Officer since Feb 2019.","Amendment to employment agreement confirms role change does not constitute 'Good Reason' for termination.","Mr. Millian's base salary remains $400,000, eligible for annual bonus up to 40% of base salary.","He brings 25 years of pharmaceutical commercial experience from EMD Serono, Vertex, Pfizer, and Sanofi."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-21-023935","json":"https://secwatch.observer/filing/0001493152-21-023935.json","markdown":"https://secwatch.observer/filing/0001493152-21-023935.md","text":"https://secwatch.observer/filing/0001493152-21-023935.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1595097/000149315221023935/0001493152-21-023935-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1595097/000149315221023935/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T01:00:26.560519+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"075b299ed6","claim":"Craig Millian was appointed as Chief Operating Officer at Corbus Pharmaceuticals Holdings, Inc..","evidence_excerpt":"On September 24, 2021, the Board of Directors (the “Board”) of Corbus Pharmaceuticals Holdings, Inc. (the “Company”) appointed Craig Millian as Chief Operating Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1595097/000149315221023935/0001493152-21-023935-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Operating Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}